» Articles » PMID: 39064141

Advances and Challenges in Spinal Cord Injury Treatments

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Jul 27
PMID 39064141
Authors
Affiliations
Soon will be listed here.
Abstract

Spinal cord injury (SCI) is a debilitating condition that is associated with long-term physical and functional disability. Our understanding of the pathogenesis of SCI has evolved significantly over the past three decades. In parallel, significant advances have been made in optimizing the management of patients with SCI. Early surgical decompression, adequate bony decompression and expansile duraplasty are surgical strategies that may improve neurological and functional outcomes in patients with SCI. Furthermore, advances in the non-surgical management of SCI have been made, including optimization of hemodynamic management in the critical care setting. Several promising therapies have also been investigated in pre-clinical studies, with some being translated into clinical trials. Given the recent interest in advancing precision medicine, several investigations have been performed to delineate the role of imaging, cerebral spinal fluid (CSF) and serum biomarkers in predicting outcomes and curating individualized treatment plans for SCI patients. Finally, technological advancements in biomechanics and bioengineering have also found a role in SCI management in the form of neuromodulation and brain-computer interfaces.

Citing Articles

Sirtuin1 in Spinal Cord Injury: Regulatory Mechanisms, Microenvironment Remodeling and Therapeutic Potential.

Li J, Cui S, Li Y, Zhang C, Chang C, Jian F CNS Neurosci Ther. 2025; 31(2):e70244.

PMID: 39915897 PMC: 11802336. DOI: 10.1111/cns.70244.


Amantadine modulates novel macrophage phenotypes to enhance neural repair following spinal cord injury.

Yang S, Yu B, Zhang Q, Zhang Y, Fu L, Zhou B J Transl Med. 2025; 23(1):60.

PMID: 39806436 PMC: 11726942. DOI: 10.1186/s12967-024-05916-y.

References
1.
Wu D, Klaw M, Connors T, Kholodilov N, Burke R, Tom V . Expressing Constitutively Active Rheb in Adult Neurons after a Complete Spinal Cord Injury Enhances Axonal Regeneration beyond a Chondroitinase-Treated Glial Scar. J Neurosci. 2015; 35(31):11068-80. PMC: 4524976. DOI: 10.1523/JNEUROSCI.0719-15.2015. View

2.
Dalkilic T, Fallah N, Noonan V, Elizei S, Dong K, Belanger L . Predicting Injury Severity and Neurological Recovery after Acute Cervical Spinal Cord Injury: A Comparison of Cerebrospinal Fluid and Magnetic Resonance Imaging Biomarkers. J Neurotrauma. 2017; 35(3):435-445. DOI: 10.1089/neu.2017.5357. View

3.
Bilgen M, Abbe R, Liu S, Narayana P . Spatial and temporal evolution of hemorrhage in the hyperacute phase of experimental spinal cord injury: in vivo magnetic resonance imaging. Magn Reson Med. 2000; 43(4):594-600. DOI: 10.1002/(sici)1522-2594(200004)43:4<594::aid-mrm15>3.0.co;2-1. View

4.
Dohrmann G, Wagner Jr F, Bucy P . The microvasculature in transitory traumatic paraplegia. An electron microscopic study in the monkey. J Neurosurg. 2011; 35(3):263-71. DOI: 10.3171/jns.1971.35.3.0263. View

5.
Brock J, Graham L, Staufenberg E, Collyer E, Koffler J, Tuszynski M . Bone Marrow Stromal Cell Intraspinal Transplants Fail to Improve Motor Outcomes in a Severe Model of Spinal Cord Injury. J Neurotrauma. 2015; 33(12):1103-14. PMC: 4904236. DOI: 10.1089/neu.2015.4009. View